Drawing for NEXOCYTE

USPTO serial 99022362

NEXOCYTE

Reviewed by CopyMark Law Group

Status 730Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
DELANEY, ZHALEH SYBIL
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 730: Status 730 means you filed the first six-month extension to delay filing a Statement of Use after a Notice of Allowance. You must file a Statement of Use or another extension before the new deadline.

Need help with NEXOCYTE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,545*

Plus Government fees of $750

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

M. David Galin

M. David Galin Tucker Ellis LLP950 Main Avenue, Suite 1100Cleveland, OH 44113United States

Goods and services

ClassDescriptionStatusFirst use
009[Sections 1b, 44e] Scientific instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances and fluid laboratory samples of the foregoing for the presence, absence, or quantity of biologics and target chemicals utilizing microfluidic and nanofluidic channels formed on or in a substrate; Scientific apparatus and instruments, namely, fluid handling device used for disposable bioprocessing applications and parts and fittings therefor; Scientific apparatus, namely, sensing and signaling devices for measurement and quality control of materials processing by laser; Chemical vapor deposition apparatus for use in research; Medical laboratory research instruments for DNA analysis; Scientific laboratory research instruments for DNA analysis; Scientific laboratory research instruments for detecting pathogens; Medical laboratory research instruments for detecting pathogens; Scientific laboratory research instruments for detecting pathogens; Portable detection and identification instruments using light sources and light detectors for detecting and identifying chemical and biological substances not for medical purposes; Computer-controlled electronic apparatus for electrophysiological measurement and testing of cells; Electronic equipment for inspection and detection of foreign material within containers; Optical inspection apparatus; Hand-operated laboratory tools for manipulating laboratory samples for use in life science research; Research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; Laboratory apparatus for automatic sample loading for scientific research purposes; Scientific instruments, namely, electronic analyzers for testing fluid laboratory samples for the presence of contaminants; Apparatus and instruments for recording, transmitting, reproducing or processing images or data; Computers and computer peripheral devices; Biological microscopesACTIVE—
010[Section 1b] Medical diagnostic apparatus for analyzing and measuring electrolytes in the body; Medical device for detecting cancer; Medical instruments, namely, biosensors for detecting infectious diseases; Immunochemical testing apparatus for medical use; Immunochemical medical diagnostic testing apparatus for detecting and measuring antibody levels; Medical diagnostic apparatus for detecting biomarkers; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell- based testing; Blood testing apparatus, namely, blood sampling tubes; Apparatus used in implementing diagnosis tests designed to detect the abnormal prion protein; Medical diagnostic apparatus for testing DNA and RNA samples; Genetic testing apparatus for medical purposesACTIVE—
040[Sections 1b, 44e] Processing of biopharmaceutical materials for others; Custom manufacture of biopharmaceuticals; Providing technical information in the field of biopharmaceutical product manufacturingACTIVE—
042[Sections 1b, 44e] Scientific and technological services, namely, research and design in the fields of biochemistry, biotechnology, biomedicine, biology, biophysics, biomechanics, bioengineering, medicine, pharmacology, 3D bioprinting, and human tissue and cell cultivation; Technical consultancy in the field of industrial research; Industrial research in the fields of biochemistry, biotechnology, biomedicine, biology, biophysics, biomechanics, bioengineering, medicine, pharmacology, and human tissue and cell cultivation; Design and development of computer hardware and software; Biological research and analysis; Biochemical research, development and analysis; Technical consultancy in the field of biochemistry; Biochemistry services, namely, custom design and development of chemical reagents and biochemical assays; Biotechnology research; Scientific and technological services, namely, testing in the field of biotechnology; Biomedical research services; Biological laboratory services, namely, laboratory services for biomanufacturing; Biological laboratory services, namely, laboratory services for biomanufacturing cultured cell tissues; Biological laboratory services, namely, laboratory services for biomanufacturing using cultivation of cells; Biological development services, namely, biological cloning services; Biological product research and development; Product development for others in the biological tissue field; Biological research services; Biological research laboratory services; Consulting services in the field of biotechnology; Scientific research relating to biology; Industrial research in the field of biotechnology; Research in the field of biophysics; Research in the field of biomechanics; Research in the field of bioengineering; Biological research laboratory services, namely, preparation of biological samples for scientific research and analysis purposes; Biological research and analysis; Scientific research in the nature of conducting clinical trials for others; Clinical research in the field of biomedicine; Medical research; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Design and development of measuring probes for biotechnological applications; Research and development in the field of biotechnology; Biological research laboratory services, namely, preparation of biological samples for testing and analysis in biological research laboratories; Research and development in the pharmaceutical and biotechnology fields; Design of machines used for process filtration in the biotechnology industry; Research of induced pluripotent stem cells; Culturing of cells for others for scientific research purposes; Research and development services in the field of microorganisms and cells; Scientific laboratory services relating to the isolation and cultivation of human tissues and cells; Providing medical and scientific research information in the field of biopharmaceutical products; Providing medical and scientific research information in the field of biopharmaceuticals; Technical consulting in the field of biopharmaceutical product studies; Consulting services in the field of biopharmaceutical product research and developmentACTIVE—
044[Sections 1b, 44e] Medical services; Veterinary services; Medical treatment using cultured cells; Medical services relating to the treatment and processing of human cells; Medical services relating to the treatment and processing of stem cells; Medical consultancy and medical information services all relating to biopharmaceutical productsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 24, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 23, 2026EX1GSOU EXTENSION 1 GRANTED—
Jul 23, 2026EXT1SOU EXTENSION 1 FILED—
Jul 23, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 27, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 2, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 2, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 26, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 4, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 20, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Oct 20, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 20, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 20, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 16, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 16, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 16, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 9, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Oct 9, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jul 10, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 10, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 10, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 9, 2025DOCKASSIGNED TO EXAMINER—
Jun 30, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 29, 2025TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Jan 29, 2025PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jan 29, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 29, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance